Nykode Therapeutics
NYKD.OL
$0.28
Share price
0.00%
Change (1 day)
-84.71%
Change (1 year)
Categories
Nykode Therapeutics (NYKD.OL) - Cash on Hand
Cash on Hand as of December 2024 : S$0.15 Billion
According to Nykode Therapeutics's latest financial reports the company has S$0.15 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Nykode Therapeutics - Cash on Hand chart (from 2020 to 2020)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | S$0.15 B | -26.67% |
| 2023-12-31 | S$0.21 B | -22.49% |
| 2022-12-31 | S$0.27 B | -10.44% |
| 2021-12-31 | S$0.30 B | 11.81% |
| 2020-12-31 | S$0.27 B | 5604.62% |
| 2019-12-31 | S$4.83 M | 85.42% |
| 2018-12-31 | S$2.6 M | -36.4% |
| 2017-12-31 | S$4.09 M |